6.65BMarket Cap
LossP/E TTM
Cogent Biosciences Inc's Company Valuation
Currency: USD Updated: 2026-07-31The current valuation score of Cogent Biosciences Inc is 8.81, ranking 53 out of 385 in the Biotechnology & Medical Research industry. Its current P/E ratio is -18.01, which is -88.72% below the recent high of -2.03 and -20.21% above the recent low of -21.65.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.